Spectral AI, Inc. (NASDAQ: MDAI) Stock Competitors & Peer Comparison
See MDAI's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MDAI and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDAI | $1.61 | +0.63% | 51.2M | -3.58 | -$0.45 | N/A |
| ALC | $67.74 | +2.59% | 33B | 21.30 | $3.18 | +0.54% |
| STE | $213.66 | +1.38% | 20.8B | 20.50 | $10.42 | +1.22% |
| QDEL | $11.12 | -5.60% | 758.3M | 8.30 | $1.34 | N/A |
| MLAB | $121.48 | +0.50% | 679.8M | 12.26 | $9.91 | +0.53% |
| BWAY | $13.63 | -2.15% | 534.6M | 34.63 | $0.39 | N/A |
| MASS | $9.73 | +2.21% | 399.2M | -16.22 | -$0.60 | N/A |
| SI | $18.35 | -0.97% | 379.9M | -10.59 | -$1.73 | N/A |
| MOBI | $10.03 | +0.20% | 333.5M | -0.53 | -$18.78 | N/A |
| ANIK | $21.19 | +1.58% | 283.6M | 43.24 | $0.49 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
MDAI vs ALC Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, ALC has a market cap of 33B. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while ALC trades at $67.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas ALC's P/E ratio is 21.30. In terms of profitability, MDAI's ROE is +1.21%, compared to ALC's ROE of +0.03%. Regarding short-term risk, MDAI is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check ALC's competition here
STERIS plc (NYSE: STE)
MDAI vs STE Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, STE has a market cap of 20.8B. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while STE trades at $213.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas STE's P/E ratio is 20.50. In terms of profitability, MDAI's ROE is +1.21%, compared to STE's ROE of +0.11%. Regarding short-term risk, MDAI is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check STE's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
MDAI vs QDEL Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, QDEL has a market cap of 758.3M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while QDEL trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas QDEL's P/E ratio is 8.30. In terms of profitability, MDAI's ROE is +1.21%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, MDAI is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check QDEL's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
MDAI vs MLAB Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, MLAB has a market cap of 679.8M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while MLAB trades at $121.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas MLAB's P/E ratio is 12.26. In terms of profitability, MDAI's ROE is +1.21%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, MDAI is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check MLAB's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
MDAI vs BWAY Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, BWAY has a market cap of 534.6M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while BWAY trades at $13.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas BWAY's P/E ratio is 34.63. In terms of profitability, MDAI's ROE is +1.21%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, MDAI is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check BWAY's competition here
908 Devices Inc. (NASDAQ: MASS)
MDAI vs MASS Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, MASS has a market cap of 399.2M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while MASS trades at $9.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas MASS's P/E ratio is -16.22. In terms of profitability, MDAI's ROE is +1.21%, compared to MASS's ROE of -0.25%. Regarding short-term risk, MDAI is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check MASS's competition here
Shoulder Innovations, Inc. (NYSE: SI)
MDAI vs SI Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, SI has a market cap of 379.9M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while SI trades at $18.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas SI's P/E ratio is -10.59. In terms of profitability, MDAI's ROE is +1.21%, compared to SI's ROE of -0.26%. Regarding short-term risk, MDAI is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
MDAI vs MOBI Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, MOBI has a market cap of 333.5M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while MOBI trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas MOBI's P/E ratio is -0.53. In terms of profitability, MDAI's ROE is +1.21%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, MDAI is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check MOBI's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
MDAI vs ANIK Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, ANIK has a market cap of 283.6M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while ANIK trades at $21.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas ANIK's P/E ratio is 43.24. In terms of profitability, MDAI's ROE is +1.21%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, MDAI is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check ANIK's competition here
Standard BioTools Inc. (NASDAQ: LAB)
MDAI vs LAB Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, LAB has a market cap of 272.7M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while LAB trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas LAB's P/E ratio is -9.95. In terms of profitability, MDAI's ROE is +1.21%, compared to LAB's ROE of -0.18%. Regarding short-term risk, MDAI is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check LAB's competition here
Edap Tms S.a. (NASDAQ: EDAP)
MDAI vs EDAP Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas EDAP's P/E ratio is -5.80. In terms of profitability, MDAI's ROE is +1.21%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, MDAI is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
MDAI vs NYXH Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, NYXH has a market cap of 160.1M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while NYXH trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas NYXH's P/E ratio is -0.63. In terms of profitability, MDAI's ROE is +1.21%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, MDAI is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check NYXH's competition here
Trinity Biotech plc (NASDAQ: TRIB)
MDAI vs TRIB Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, TRIB has a market cap of 151.6M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while TRIB trades at $7.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas TRIB's P/E ratio is -0.12. In terms of profitability, MDAI's ROE is +1.21%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, MDAI is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check TRIB's competition here
Apyx Medical Corporation (NASDAQ: APYX)
MDAI vs APYX Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, APYX has a market cap of 127.2M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while APYX trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas APYX's P/E ratio is -15.10. In terms of profitability, MDAI's ROE is +1.21%, compared to APYX's ROE of -0.79%. Regarding short-term risk, MDAI is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
MDAI vs SKIN Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, SKIN has a market cap of 90.7M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while SKIN trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas SKIN's P/E ratio is -3.18. In terms of profitability, MDAI's ROE is +1.21%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, MDAI is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check SKIN's competition here
DarioHealth Corp. (NASDAQ: DRIO)
MDAI vs DRIO Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, DRIO has a market cap of 50.2M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while DRIO trades at $7.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas DRIO's P/E ratio is -1.17. In terms of profitability, MDAI's ROE is +1.21%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, MDAI is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check DRIO's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
MDAI vs BEAT Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, BEAT has a market cap of 22.5M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while BEAT trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas BEAT's P/E ratio is -0.80. In terms of profitability, MDAI's ROE is +1.21%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, MDAI is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check BEAT's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
MDAI vs BEATW Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, BEATW has a market cap of 6M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas BEATW's P/E ratio is -0.02. In terms of profitability, MDAI's ROE is +1.21%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, MDAI is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
MDAI vs WOK Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, WOK has a market cap of 4.6M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while WOK trades at $1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas WOK's P/E ratio is N/A. In terms of profitability, MDAI's ROE is +1.21%, compared to WOK's ROE of -0.19%. Regarding short-term risk, MDAI is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
MDAI vs QTEXW Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, MDAI's ROE is +1.21%, compared to QTEXW's ROE of N/A. Regarding short-term risk, MDAI is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
MDAI vs ITOC Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, ITOC has a market cap of 2.7M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while ITOC trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas ITOC's P/E ratio is -0.93. In terms of profitability, MDAI's ROE is +1.21%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, MDAI is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check ITOC's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
MDAI vs FEED Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, FEED has a market cap of 2.7M. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while FEED trades at $3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas FEED's P/E ratio is -0.02. In terms of profitability, MDAI's ROE is +1.21%, compared to FEED's ROE of -0.60%. Regarding short-term risk, MDAI is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check FEED's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
MDAI vs TIVC Comparison September 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 51.2M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, MDAI is priced at $1.61 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.58, whereas TIVC's P/E ratio is -0.04. In terms of profitability, MDAI's ROE is +1.21%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, MDAI is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check TIVC's competition here